SCHEMBL7793503

SCHEMBL7793503

CCCCN(CC)C(=O)c1cnc2c([N+](=O)[O-])cccc2c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HPGD P15428 2/20 0.44
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 1/20 0.40
VCAM1 P19320 2/20 0.39
EIF4A1 P60842 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RAB9A P51151 1/20 0.36
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537393 0.77 MEN1 (0.54) ALDH1A1KMT2AMEN1KDM4ETDP1
SCHEMBL7803244 0.76 ALDH1A1 (0.48) ALDH1A1HPGDKMT2AMEN1KDM4E
SCHEMBL4785490 0.76 KMT2A (0.64) ALDH1A1KMT2AMEN1KDM4ETDP1
SCHEMBL6985429 0.75 KMT2A (0.54) ALDH1A1KMT2AMEN1KDM4ETDP1
SCHEMBL7799276 0.73 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1KDM4ETDP1
SCHEMBL24497046 0.72 TP53 (0.54) ALDH1A1KMT2AMEN1KDM4EMAPT
SCHEMBL6984531 0.71 MEN1 (0.53) ALDH1A1KMT2AMEN1KDM4EMAPT
SCHEMBL8011129 0.71 KMT2A (0.46) ALDH1A1HPGDKMT2AMEN1KDM4E
SCHEMBL11613355 0.71 KMT2A (0.61) ALDH1A1HPGDKMT2AMEN1TDP1
SCHEMBL6537483 0.69 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010001101-A1 Phenanthroline derivatives ZENECA LIMITED 2001-05-10 US disclosed
EP-1027351-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 2000-08-16 EP disclosed
US-5916898-A ANTIFIBROPROLIFERTIVE, ENZYME INHIBITORS OF PYROLYL 4-HYDROXYLASE, ANTIARTHRITIC AGENTS ZENECA LIMITED (GB) 1999-06-29 US disclosed
WO-1999021860-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010001101-A1 Phenanthroline derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, COL1A1, COL2A1 ALDH1A1 425/4885HPGD 802/4885KMT2A 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.